Related Experiment Videos
Differentiating genomics companies
1Prelude Technology Investments, Cambridge CB4 5PJ, UK. rob.james@prelude-technology.co.uk
Nature Biotechnology
|February 5, 2000
Abstract:
As the value of raw sequence data diminishes, genomics companies are evolving new competencies as providers of information, therapeutic products, or novel technology.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Maternal and neonatal outcomes in pregnant patients with Brugada Syndrome - a multicentre retrospective study (2014-2025).
International journal of obstetric anesthesia·2026
Clinical value of amylase and its prognostic accuracy in guinea pigs (Cavia porcellus).
The Journal of small animal practice·2025
Sudden cardiac death associated with severe atherosclerosis in a young dog.
Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2025
Assessing the appropriateness of antifungal prescribing: key results from the implementation of a novel audit tool in Australian hospitals.
The Journal of antimicrobial chemotherapy·2025
Proteome-wide identification of the druggable CRBN interactome.
Nature biotechnology·2026
Unveiling the Immune Mechanisms of Hypertension With Single-Cell Transcriptome-Wide Mendelian Randomization.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Case Report: Functional validation of a PKD1 c.7489 + 5G>A variant in an ADPKD family.
Frontiers in genetics·2026
An analysis of intestinal morphology and incretin-producing cells after sleeve gastrectomy in male mice.
Journal of molecular endocrinology·2026
MRI-based assessment of fetal brain gyrification: Reliability across two methods.
Neuroimage. Reports·2026
Structural variants contribute substantially to complex trait heritability.
Research square·2026